In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA)

Clinical and Experimental Immunology

Volumn 114, Issue 2, 1998, Pages 284-292

  Asselin, S ^a   Conjeaud, H ^a   Fradelizi, D ^a   Breban, M ^a,b  

^a Institut de Rhumatologie Hopital Cochin   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

Cytokines; Passive immunotherapy; Rheumatoid arthritis; T cell

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OKT 3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PASSIVE IMMUNIZATION; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; ANTIGENS, CD30; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOPOIESIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MEMBRANE PROTEINS; MICE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0031791122     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00709.x     Document Type: Article

References (52)

1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397-440.
2. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996; 85:307-10.
3. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
4. Romagnani S. Lymphokine production by human T cells in disease stales. Annu Rev Immunol 1994; 12:227-57.
5. + T cells in the pathogenesis of organ-specific autoimmune disease. Immunol Today 1995; 16:34-38.
6. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26:1511-8.
7. Doncarli A, Stasiuk LM, Founier C, Abeshira-Amar O. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 1997; 27:1451-8.
8. Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992; 35: 603-10.
9. Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Forre Q, Natvig JB. Rheumatoid inflammatory T cell clones express mostly TH1 but also TH2 and mixed (TH0-like) cytokine patterns. Scand J Immunol 1993; 38:75-82.
10. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91:8562-6.
11. Bucht A, Larsson P, Weisbrot L, Thorne C, Pisa P, Smedegard G, Keystone EC, Grönberg A. Expression of interferon-gamma (IFN-γ), IL-10, IL-12 and transforming factor-beta (TGF-β) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996; 103:357-67.
12. Dolhain RJEM, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1961-9.
13. Shulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Elevated Th1-or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. J Immunol 1995; 155:5029-37.
14. Hahn G, Stuhlmüller B, Hain N, Kalden JR, Pfizenmaier K, Burmester GR. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest 1993; 91:862-70.
15. van Roon JAG, van Roy JLAM, Duits A, Lafeber FPJG, Bijlsma JWJ. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 1995; 54:836-40.
16. Chomarat P, Banchereau J, Miossec P. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995; 38:1046-54.
17. Isomäki P, Luukkainen R, Toivanen P, Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1693-702.
18. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 1992; 35:874-83.
19. Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T, Yamashita N, Maruyama M, Kobayashi M. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 1995; 22:2020-6.
20. Dechanet J, Riossan M-C, Banchereau J, Miossec P. Interleukin 4, but not interleukin 10, regulates the production of inflammatory mediators by rheumatoid synoviocytes. Cytokine 1995; 7:176-83.
21. Chomarat P, Vannier E, Dechanet J, Riossan MC, Banchereau J, Dinarello CA, Miossec P. Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995; 154:1432-9.
22. Dechanet J, Briolay J, Riossan M-C, Chomarat P, Galizzi J-P, Banchereau J, Miossec P. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 1993; 151:4908-17.
23. Miossec P, Chomarat P, Dechanet J, Moreau J-F, Roux J-P, Delmas P, Banchereau J. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 1994; 37: 1715-22.
24. Röcken M, Racke M, Shevach EM. IL-4-induced immune deviation as antigen-specitic therapy for inflammatory autoimmune disease. Immunol Today 1996; 17:225-31.
25. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994; 180: 1961-6.
26. + donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 1995; 155:585-93.
27. Falcone M, Bloom BR. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyclitis. J Exp Med 1997; 185:901-7.
28. + T cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177:627-36.
29. Asselin S, Conjeaud H, Minty A, Fradelizi D, Breban M. Stable polarization of peripheral blood T cells towards type 1 or type 2 phenotype after polyclonal activation. Eur J Immunol 1998; 28:532-9.
30. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
31. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18:263-6.
32. Bradley LM, Yoshimoto K, Swain SL. The cytokines IL-4, IFN-γ, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro. J Immunol 1995; 155:1713-24.
33. Pitzalis C, Kingsley G, Haskard D, Panayi G. The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1988; 18:1397-404.
34. Cush JJ, Pietschmann P, Oppenheimer-Marks N, Lipsky PE. The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum 1992; 35: 1434-44.
35. Allen ME, Young SP, Michell RH, Bacon PA. Altered T lymphocyte signaling in rheumatoid arthritis. Eur J Immunol 1995; 25:2547-54.
36. dim, CD27 memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:844-54.
37. Gayewski TF, Fitch F. Antiproliferative eltcets of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation ol Th2 hut not Th1 murine helper T lymphocytes. J Immunol 1988; 140:4245-52.
38. + T cells are associated with ILN-γ production. FASEB J 1996; 10:769-75.
39. Combe B, Pope RM, Fischbach M, Darnell B, Baron S, Talal N. Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol 1985; 59:520-8.
40. Plater-Zyberk C, Rockett KA, Maini RN. Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis. Clin Exp Immunol 1988; 73:93-97.
41. Cope AP, Liblau RS, Yang X-D et al. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 1997; 185:1573-84.
42. + T cell clones and resting T cells. J Immunol 1993; 150:4754-65.
43. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:96-104.
44. Emery P, Panayi GS, Nouri AM. Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis. Clin Exp Immunol 1984; 57:123-9.
45. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J Immunol 1990; 144:2211-5.
46. + human T cells. J Immunol 1991; 146:4209-14.
47. + T cells. J Immunol 1997; 158:1085-94.
48. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172:921-9.
49. Rooney JW, Hodge MR, McCaffrey PG, Rao A, Glimcher LH. A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J 1994; 13:625-33.
50. van Dinther-Janssen ACHM, Horst E, Koopman G, Newmann W, Scheper RJ, Meijer CJLM, Pals ST. The VLA-4/VCAM-1 pathway is invoked in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol 1991; 147:4207-10.
51. Oppenheimei-Marks N, Davis I.S. Tompkins Bogue D, Ramberg J, Lipsky PE. Differential ulilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991; 147:2913-21.
52. Kavanaugh AF, Lightfoot E, Lipsky PE, Oppenheimer-Marks N. Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. J Immunol 1991; 146:4149-56.